Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors

Jalmira Mulchande, Rita C. Guedes, Wing Yin Tsang, Michael I. Page, Rui Moreira, Jim Iley

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A new class of inhibitors 4-oxo-β-lactams (azetidine-2,4-diones), containing the required structural elements for molecular recognition, inhibit porcine pancreatic elastase (PPE) but show a dramatically lower reactivity toward hydroxide compared with the analogous inhibitors 3-oxo-β-sultams. Inhibition is the result of acylation of the active site serine and electron-withdrawing substituents at the N-(4-aryl) position in 3,3-diethyl-N-aryl derivatives increasing the rate of enzyme acylation and generating a Hammett ρ-value of 0.65. Compared with a ρ-value of 0.96 for the rates of alkaline hydrolysis of the same series, this is indicative of an earlier transition state for the enzyme-catalyzed reaction. Docking studies indicate favorable noncovalent interactions of the inhibitor with the enzyme. Compound 2i, the most potent inhibitor against PPE, emerged as a very potent HLE inhibitor, with a second-order rate for enzyme inactivation of ∼5 × 105 M-1 s-1.

LanguageEnglish
Pages1783-1790
Number of pages8
JournalJournal of Medicinal Chemistry
Volume51
Issue number6
Early online date22 Feb 2008
DOIs
Publication statusPublished - 2008

Fingerprint

Pancreatic Elastase
beta-Lactams
Acylation
Enzymes
Swine
Enzyme Inhibitors
Serine
Catalytic Domain
Hydrolysis
Electrons
azetidine

Cite this

Mulchande, J., Guedes, R. C., Tsang, W. Y., Page, M. I., Moreira, R., & Iley, J. (2008). Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors. Journal of Medicinal Chemistry, 51(6), 1783-1790. https://doi.org/10.1021/jm701257h
Mulchande, Jalmira ; Guedes, Rita C. ; Tsang, Wing Yin ; Page, Michael I. ; Moreira, Rui ; Iley, Jim. / Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 6. pp. 1783-1790.
@article{7b6bd5fa35e34c6abc3a6d373a43d044,
title = "Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors",
abstract = "A new class of inhibitors 4-oxo-β-lactams (azetidine-2,4-diones), containing the required structural elements for molecular recognition, inhibit porcine pancreatic elastase (PPE) but show a dramatically lower reactivity toward hydroxide compared with the analogous inhibitors 3-oxo-β-sultams. Inhibition is the result of acylation of the active site serine and electron-withdrawing substituents at the N-(4-aryl) position in 3,3-diethyl-N-aryl derivatives increasing the rate of enzyme acylation and generating a Hammett ρ-value of 0.65. Compared with a ρ-value of 0.96 for the rates of alkaline hydrolysis of the same series, this is indicative of an earlier transition state for the enzyme-catalyzed reaction. Docking studies indicate favorable noncovalent interactions of the inhibitor with the enzyme. Compound 2i, the most potent inhibitor against PPE, emerged as a very potent HLE inhibitor, with a second-order rate for enzyme inactivation of ∼5 × 105 M-1 s-1.",
author = "Jalmira Mulchande and Guedes, {Rita C.} and Tsang, {Wing Yin} and Page, {Michael I.} and Rui Moreira and Jim Iley",
year = "2008",
doi = "10.1021/jm701257h",
language = "English",
volume = "51",
pages = "1783--1790",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

Mulchande, J, Guedes, RC, Tsang, WY, Page, MI, Moreira, R & Iley, J 2008, 'Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors', Journal of Medicinal Chemistry, vol. 51, no. 6, pp. 1783-1790. https://doi.org/10.1021/jm701257h

Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors. / Mulchande, Jalmira; Guedes, Rita C.; Tsang, Wing Yin; Page, Michael I.; Moreira, Rui; Iley, Jim.

In: Journal of Medicinal Chemistry, Vol. 51, No. 6, 2008, p. 1783-1790.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Azetidine-2,4-diones (4-oxo-β-lactams) as Scaffolds for Designing Elastase Inhibitors

AU - Mulchande, Jalmira

AU - Guedes, Rita C.

AU - Tsang, Wing Yin

AU - Page, Michael I.

AU - Moreira, Rui

AU - Iley, Jim

PY - 2008

Y1 - 2008

N2 - A new class of inhibitors 4-oxo-β-lactams (azetidine-2,4-diones), containing the required structural elements for molecular recognition, inhibit porcine pancreatic elastase (PPE) but show a dramatically lower reactivity toward hydroxide compared with the analogous inhibitors 3-oxo-β-sultams. Inhibition is the result of acylation of the active site serine and electron-withdrawing substituents at the N-(4-aryl) position in 3,3-diethyl-N-aryl derivatives increasing the rate of enzyme acylation and generating a Hammett ρ-value of 0.65. Compared with a ρ-value of 0.96 for the rates of alkaline hydrolysis of the same series, this is indicative of an earlier transition state for the enzyme-catalyzed reaction. Docking studies indicate favorable noncovalent interactions of the inhibitor with the enzyme. Compound 2i, the most potent inhibitor against PPE, emerged as a very potent HLE inhibitor, with a second-order rate for enzyme inactivation of ∼5 × 105 M-1 s-1.

AB - A new class of inhibitors 4-oxo-β-lactams (azetidine-2,4-diones), containing the required structural elements for molecular recognition, inhibit porcine pancreatic elastase (PPE) but show a dramatically lower reactivity toward hydroxide compared with the analogous inhibitors 3-oxo-β-sultams. Inhibition is the result of acylation of the active site serine and electron-withdrawing substituents at the N-(4-aryl) position in 3,3-diethyl-N-aryl derivatives increasing the rate of enzyme acylation and generating a Hammett ρ-value of 0.65. Compared with a ρ-value of 0.96 for the rates of alkaline hydrolysis of the same series, this is indicative of an earlier transition state for the enzyme-catalyzed reaction. Docking studies indicate favorable noncovalent interactions of the inhibitor with the enzyme. Compound 2i, the most potent inhibitor against PPE, emerged as a very potent HLE inhibitor, with a second-order rate for enzyme inactivation of ∼5 × 105 M-1 s-1.

UR - http://www.scopus.com/inward/record.url?scp=41149169679&partnerID=8YFLogxK

U2 - 10.1021/jm701257h

DO - 10.1021/jm701257h

M3 - Article

VL - 51

SP - 1783

EP - 1790

JO - Journal of Medicinal Chemistry

T2 - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -